Program areas at The Adenoid Cystic Carcinoma Research Foundation
Translation to The clinic: accrf supports and coordinates Research into treatments most likely to lead to clinical ebenfit for Adenoid Cystic Carcinoma patients. Drug discovery, drug development, preclinical drug screening and correlative studies are crucial to The initiation and optimal conduct of clinical trials.
Basic Research: accrf supports and coordinates The descriptive and functional studies that identify molecular targets and pathways that permit Adenoid Cystic Carcinoma to progress. By focusing on The mechanisms of action, researchers may discover more quickly The achilles' heel of The disease.
Grants made by The Adenoid Cystic Carcinoma Research Foundation
| Grantee | Grant description | Grant year | Amount |
|---|
| Dana-Farber Cancer Institute | Support for the Study of Targeted Protein Degradation Approaches To Define the Molecular Mechanisms of Myb Oncoproteins in Acc | 2022-12 | $242,712 |
| Johns Hopkins University (JHU) | Support for A Phase 2, Single-Arm, Multi-Center Study of 177lu-psma (177lu-pnt2002) in Patients With Psma-Positive Adenoid Cystic Carcinoma | 2022-12 | $100,000 |
| Dana-Farber Cancer Institute | Support for Therapeutic Drug Screening Using A Novel Implantable Microdevice (Imd) in Adenoid Cysticcarcinoma (Acc): A Window of Opportunity Study | 2022-12 | $25,000 |
| ...and 3 more grants made |
Who funds The Adenoid Cystic Carcinoma Research Foundation
Grants from foundations and other nonprofits
Personnel at The Adenoid Cystic Carcinoma Research Foundation
| Name | Title | Compensation | Date of data |
|---|
| Marnie A Kaufman | Director and Chief Financial Officer | $0 | 2022-12-31 |
| Jeffrey A Kaufman | Executive Director | $150,000 | 2023-05-14 |
| Nicole Spardy Burr | Director of Research | $124,166 | 2022-12-31 |
| Ralph Mollis | Treasurer | $0 | 2022-12-31 |
| Thomas Dilenge | Board Vice Chair | $0 | 2022-12-31 |
Financials for The Adenoid Cystic Carcinoma Research Foundation
| Revenues | FYE 12/2022 | FYE 12/2021 | % Change |
|---|
| Total grants, contributions, etc. | $807,996 | $1,588,834 | -49.1% |
| Program services | $551,076 | $837,896 | -34.2% |
| Investment income and dividends | $11,819 | $403 | 2832.8% |
| Tax-exempt bond proceeds | $0 | $0 | - |
| Royalty revenue | $0 | $0 | - |
| Net rental income | $0 | $0 | - |
| Net gain from sale of non-inventory assets | $15,764 | $0 | 999% |
| Net income from fundraising events | $0 | $0 | - |
| Net income from gaming activities | $0 | $0 | - |
| Net income from sales of inventory | $0 | $0 | - |
| Miscellaneous revenues | $0 | $0 | - |
| Total revenues | $1,386,655 | $2,427,133 | -42.9% |
Organizations like The Adenoid Cystic Carcinoma Research Foundation
| Organization | Type | Location | Revenue |
|---|
| Israel Cancer Research Fund | 501(c)(3) | New York, NY | $5,734,601 |
| Fanconi Anemia Research Fund | 501(c)(3) | Eugene, OR | $3,171,988 |
| Leukemia Research Foundation (LRF) | 501(c)(3) | Northfield, IL | $4,193,244 |
| Pediatric Cancer Research Foundation (PCRF) | 501(c)(3) | Irvine, CA | $3,117,985 |
| TJ Martell Foundation for Cancer Research | 501(c)(3) | Nashville, TN | $715,073 |
| Lung Cancer Research Foundation (LCRF) | 501(c)(3) | New York, NY | $6,603,556 |
| Neuroendocrine Tumor Research Foundation | 501(c)(3) | Boston, MA | $3,075,371 |
| Acpmp)appendix Cancerpseudomyxoma Peritonei Research Foundation | 501(c)(3) | Springfield, PA | $467,148 |
| FRAXA Research Foundation | 501(c)(3) | Newburyport, MA | $2,018,041 |
| Curing Kids Cancer | 501(c)(3) | Irving, TX | $3,264,927 |
Data update history
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
July 9, 2023
Posted financials
Added Form 990 for fiscal year 2022
July 1, 2023
Updated personnel
Identified 3 new personnel
June 27, 2023
Used new vendors
Identified 1 new vendor, including
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
Health
Characteristics
Conducts researchOperates internationallyNational levelAuction fundraisersTax deductible donations
General information
- Address
- PO Box 442
- Needham, MA 02494
- Metro area
- Boston-Cambridge-Newton, MA-NH
- County
- Norfolk County, MA
- Website URL
- accrf.org/Â
- Phone
- (781) 248-9699
IRS details
- EIN
- 20-6745475
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2005
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- H30: Cancer Research
- NAICS code, primary
- 813212: Health and Disease Research Fundraising Organizations
- Parent/child status
- Independent
Free account sign-up
Want updates when The Adenoid Cystic Carcinoma Research Foundation has new information, or want to find more organizations like The Adenoid Cystic Carcinoma Research Foundation?
Create free Cause IQ account